Who Paid My Doc
Comaneci 17
Device Neurovascular
PDI 07290015107150
General payments
$1,280,435
Research payments
$741,629
Through program year 2025, $1,280,435 in general payments and $741,629 in research payments were reported against Comaneci 17 (Neurovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $324,814 | 502 |
| 2025 | Research | $16,246 | 6 |
| 2024 | General | $271,823 | 665 |
| 2024 | Research | $137,673 | 32 |
| 2023 | General | $280,287 | 598 |
| 2023 | Research | $260,528 | 48 |
| 2022 | General | $267,929 | 314 |
| 2022 | Research | $184,417 | 29 |
| 2021 | General | $135,582 | 146 |
| 2021 | Research | $142,765 | 18 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 30 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,225 general · 133 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.